Tarmac Products, Inc. d.b.a. Axara Pharmaceuticals

FDA Regulatory Profile

Tarmac Products, Inc. d.b.a. Axara Pharmaceuticals appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-311-2013, Class II) was initiated on March 16, 2013.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-311-2013Class II"Well at Wallgreens" Regular Strength Antacid Liquid (Alumina/Magnesia/Simethicone/Antacid & Anti GaMarch 16, 2013